- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Mebeverine is a drug used to treat gastrointestinal disorders such as irritable bowel syndrome (IBS), cramps, and spasms. It works by blocking the action of a chemical in the body called acetylcholine, which is responsible for causing muscle contractions. Mebeverine is available in tablet, capsule, and liquid form. It is usually taken three times a day, with or without food.
Mebeverine is a popular choice for treating gastrointestinal disorders due to its effectiveness and low risk of side effects. It is generally well tolerated and can be used for long-term treatment. It is also available over the counter in some countries.
The market for Mebeverine is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include GlaxoSmithKline, Pfizer, Sanofi, and Novartis. Other companies include Mylan, Teva, and Sun Pharmaceuticals. Show Less Read more